The Canadian life sciences hub that may not be on your FDI radar (but should be)
Investment Monitor explores the vibrant and emerging life sciences scene in Hamilton, Ontario.
Partners
Latest in
Partners
Partner content
Building a global supply chain network for clinical trial products
On-time deliveries are paramount in the pharmaceutical world. But ensuring expedited transfer from one location to another is only a…
Partner content
The rise of eConsent adoption: Why now is the time to leave paper-based consent behind
Clinical Trials Arena speaks to Suvoda’s Andrés Escallón on the advantages and barriers to eConsent adoption.
Partner content
Protection through preparation: How self-test kits became essential
The value of self-test kits has surged in the last two years and these items are now viewed as an…
Partner content
What factors are driving life sciences FDI in 2022?
Investment Monitor explores top drivers for greenfield FDI in the life sciences, including examples from Charleston, South Carolina – a…
Partner content
What factors are driving life sciences FDI in 2022?
Investment Monitor explores top drivers for greenfield FDI in the life sciences, including examples from Charleston, South Carolina – a…
Partner content
Orphan drugs and where to launch them: The keys to Europe’s forgotten territories
Although orphan drugs are developed to address the unmet medical needs of rare disease patients, traditional launch strategies have failed…
Partner content
A preferred destination: what’s driving Asia Pacific’s growth as a clinical trial hotspot
Research from GlobalData shows that the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from…